{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Pasireotide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pasireotide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pasireotide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "pasireotide",
    "trial_2_text": "Pasireotide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Pasireotide Supplement: 60 participants will take Pasireotide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pasireotide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pasireotide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.26694995164871216,
      "78": 0.2512401044368744,
      "177": 0.19763801991939545,
      "123": 0.17946647107601166,
      "20": 0.1750396192073822,
      "17": 0.15006384253501892,
      "189": 0.13430148363113403,
      "68": 0.13237541913986206,
      "37": 0.13122768700122833,
      "188": 0.12212739139795303,
      "9": 0.12023044377565384,
      "173": 0.11955412477254868,
      "49": 0.11579550802707672,
      "228": 0.11155319958925247,
      "350": 0.10999831557273865,
      "2": 0.1097288504242897,
      "21": 0.10914389789104462,
      "77": 0.1083640456199646,
      "14": 0.10566819459199905,
      "46": 0.10475530475378036,
      "67": 0.10120421648025513,
      "29": 0.0999656692147255,
      "200": 0.09415736794471741,
      "64": 0.09002869576215744,
      "243": 0.08791700005531311,
      "28": 0.08764079213142395,
      "79": 0.08567987382411957,
      "179": 0.08207258582115173,
      "101": 0.08050188422203064,
      "193": 0.08011265844106674,
      "27": 0.08010938763618469,
      "114": 0.0741930902004242,
      "82": 0.07202790677547455,
      "76": 0.0716361552476883,
      "131": 0.06849392503499985,
      "61": 0.06813710182905197,
      "126": 0.0665607899427414,
      "5": 0.065069779753685,
      "239": 0.063801109790802,
      "104": 0.06374852359294891,
      "85": 0.0628511905670166,
      "180": 0.06256473809480667,
      "194": 0.0625390112400055,
      "261": 0.06224171817302704,
      "86": 0.061165958642959595,
      "147": 0.06094985827803612,
      "276": 0.059116728603839874,
      "288": 0.05806374177336693,
      "30": 0.05784198269248009,
      "186": 0.057628534734249115,
      "151": 0.05543464794754982,
      "355": 0.055387794971466064,
      "122": 0.05379549041390419,
      "35": 0.05283782258629799,
      "164": 0.05222218111157417,
      "249": 0.0508844368159771,
      "191": 0.04979456216096878,
      "139": 0.04840746149420738,
      "38": 0.04825529456138611,
      "282": 0.047914132475852966,
      "144": 0.047244925051927567,
      "96": 0.046909149736166,
      "297": 0.04689957946538925,
      "269": 0.046584609895944595,
      "130": 0.04646281525492668,
      "18": 0.04546668007969856,
      "253": 0.045194271951913834,
      "166": 0.04405079782009125,
      "234": 0.043971702456474304,
      "72": 0.04387115314602852,
      "339": 0.04299832507967949,
      "31": 0.04276340454816818,
      "97": 0.04140077158808708,
      "33": 0.04113911837339401,
      "396": 0.04101356863975525,
      "102": 0.04032879322767258,
      "204": 0.04026225954294205,
      "341": 0.03996529057621956,
      "286": 0.03986549749970436,
      "163": 0.03928310424089432,
      "116": 0.03865444287657738,
      "69": 0.038652610033750534,
      "75": 0.038616303354501724,
      "212": 0.03844645246863365,
      "142": 0.038185592740774155,
      "92": 0.03800260275602341,
      "132": 0.0377800352871418,
      "221": 0.03772404417395592,
      "211": 0.03754982724785805,
      "154": 0.036912377923727036,
      "356": 0.03636174276471138,
      "256": 0.03629826381802559,
      "121": 0.03599545732140541,
      "454": 0.03542755916714668,
      "136": 0.03531472012400627,
      "508": 0.0349702462553978,
      "466": 0.03480442240834236,
      "1": 0.0347868949174881,
      "441": 0.03440946340560913,
      "262": 0.034407828003168106
    },
    "trial_2_ae": {
      "87": 0.26694995164871216,
      "78": 0.2512401044368744,
      "177": 0.19763801991939545,
      "123": 0.17946647107601166,
      "20": 0.1750396192073822,
      "17": 0.15006384253501892,
      "189": 0.13430148363113403,
      "68": 0.13237541913986206,
      "37": 0.13122768700122833,
      "188": 0.12212739139795303,
      "9": 0.12023044377565384,
      "173": 0.11955412477254868,
      "49": 0.11579550802707672,
      "228": 0.11155319958925247,
      "350": 0.10999831557273865,
      "2": 0.1097288504242897,
      "21": 0.10914389789104462,
      "77": 0.1083640456199646,
      "14": 0.10566819459199905,
      "46": 0.10475530475378036,
      "67": 0.10120421648025513,
      "29": 0.0999656692147255,
      "200": 0.09415736794471741,
      "64": 0.09002869576215744,
      "243": 0.08791700005531311,
      "28": 0.08764079213142395,
      "79": 0.08567987382411957,
      "179": 0.08207258582115173,
      "101": 0.08050188422203064,
      "193": 0.08011265844106674,
      "27": 0.08010938763618469,
      "114": 0.0741930902004242,
      "82": 0.07202790677547455,
      "76": 0.0716361552476883,
      "131": 0.06849392503499985,
      "61": 0.06813710182905197,
      "126": 0.0665607899427414,
      "5": 0.065069779753685,
      "239": 0.063801109790802,
      "104": 0.06374852359294891,
      "85": 0.0628511905670166,
      "180": 0.06256473809480667,
      "194": 0.0625390112400055,
      "261": 0.06224171817302704,
      "86": 0.061165958642959595,
      "147": 0.06094985827803612,
      "276": 0.059116728603839874,
      "288": 0.05806374177336693,
      "30": 0.05784198269248009,
      "186": 0.057628534734249115,
      "151": 0.05543464794754982,
      "355": 0.055387794971466064,
      "122": 0.05379549041390419,
      "35": 0.05283782258629799,
      "164": 0.05222218111157417,
      "249": 0.0508844368159771,
      "191": 0.04979456216096878,
      "139": 0.04840746149420738,
      "38": 0.04825529456138611,
      "282": 0.047914132475852966,
      "144": 0.047244925051927567,
      "96": 0.046909149736166,
      "297": 0.04689957946538925,
      "269": 0.046584609895944595,
      "130": 0.04646281525492668,
      "18": 0.04546668007969856,
      "253": 0.045194271951913834,
      "166": 0.04405079782009125,
      "234": 0.043971702456474304,
      "72": 0.04387115314602852,
      "339": 0.04299832507967949,
      "31": 0.04276340454816818,
      "97": 0.04140077158808708,
      "33": 0.04113911837339401,
      "396": 0.04101356863975525,
      "102": 0.04032879322767258,
      "204": 0.04026225954294205,
      "341": 0.03996529057621956,
      "286": 0.03986549749970436,
      "163": 0.03928310424089432,
      "116": 0.03865444287657738,
      "69": 0.038652610033750534,
      "75": 0.038616303354501724,
      "212": 0.03844645246863365,
      "142": 0.038185592740774155,
      "92": 0.03800260275602341,
      "132": 0.0377800352871418,
      "221": 0.03772404417395592,
      "211": 0.03754982724785805,
      "154": 0.036912377923727036,
      "356": 0.03636174276471138,
      "256": 0.03629826381802559,
      "121": 0.03599545732140541,
      "454": 0.03542755916714668,
      "136": 0.03531472012400627,
      "508": 0.0349702462553978,
      "466": 0.03480442240834236,
      "1": 0.0347868949174881,
      "441": 0.03440946340560913,
      "262": 0.034407828003168106
    }
  },
  "safety": {
    "trial_1_safety": 0.42311224341392517,
    "trial_2_safety": 0.42311224341392517
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47587060928344727
  }
}